Latest News
MRI is cost-effective replacement for CT scans to monitor early stage testicular cancer
New findings from the TRISST study reveal that it would be cost effective to replace potentially harmful CT scans with MRI to monitor men after surgery for early stage testicular cancer.
New low-dose COVID-19 vaccine safely generates immune responses in 80%
A low-dose COVID-19 vaccine harnessing self-amplifying RNA (saRNA) can trigger an immune response in the majority without any serious side effects, according to phase II trial results from the COVAC1 study.
Success on the international stage for an ACORD Fellow
Many congratulations to ACORD Fellow Dr Arpan Mehta on winning the Best Talk award at this year's CURE-ND Clinical Workshop in Paris.
HIV self-testing increases uptake without reducing link to care or STI testing
Offering free online HIV self-tests increases uptake in men (including trans men) and trans women who have sex with men, and does not reduce linkage to care.
Our Capacity Strengthening Hub launches on The Global Health Network today!
The MRC CTU Capacity Strengthening Hub has launched today on The Global Health Network digital platform.